本頁面由Tiger Fintech (Singapore) Pte. Ltd.提供服務

Denali Therapeutics Inc.

15.43
+0.64004.33%
盤後15.730.3000+1.94%19:05 EDT
成交量:418.83萬
成交額:6,390.06萬
市值:22.56億
市盈率:-5.49
高:15.66
開:14.95
低:14.87
收:14.79
52周最高:33.33
52周最低:10.57
股本:1.46億
流通股本:1.32億
量比:1.62
換手率:3.17%
股息:- -
股息率:- -
每股收益(TTM):-2.8082
每股收益(LYR):-2.5705
淨資產收益率:-39.69%
總資產收益率:-24.99%
市淨率:2.20
市盈率(LYR):-6.00

資料載入中...

2025/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2025/01/07

重要事件披露

Form 8-K - Current report
2025/01/02

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/12/31

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/18

重要事件披露

Form 8-K - Current report
2024/11/12

超過5%披露

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
2024/11/12

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/08

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

超過5%披露

Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
2024/11/07

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/11/06

季度報告

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
2024/11/06

重要事件披露

Form 8-K - Current report
2024/10/18

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/10/10

重要事件披露

Form 8-K - Current report
2024/09/30

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/09/13

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities
2024/08/21

關聯方擬減持公告

Form 144 - Report of proposed sale of securities